{"retracted":false,"update":{"timestamp":1378166400000,"doi":"10.1007/s10637-013-0021-1","type":"correction"},"doi":"10.1007/s10637-013-9953-8","journal":"Investigational New Drugs","publisher":"Springer Nature","title":"Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics"}
